FDA approves BioMarin drug to treat dwarfism in children
The US agency has granted approval to Voxzogo, an injectable drug designed to aid growth in children with achondroplasia, the most common form of dwarfism.
Archives for November 22, 2021
Reify Health launches tool to gauge clinical trial diversity
The StudyTeam Diversity Reporting feature is intended to aid sites and sponsors measure their efforts to reach patients from underrepresented communities.